192 results
Page 8 of 10
8-K
ngx8u9l0xxpd d3
3 Apr 20
Amendments to Articles of Incorporation or Bylaws
4:30pm
8-K
EX-99.1
j3jatfqj
24 Feb 20
Aeglea BioTherapeutics Reports Fourth-Quarter and Full-Year 2019 Financial Results, Highlights Recent Milestones
7:30am
8-K/A
g8o x72wzl2q4q4n8s
13 Jan 20
Regulation FD Disclosure
5:20pm
8-K
ins46juh0 evwstzoa
13 Jan 20
Company Expects to Initiate a Phase 1/2 Trial in the Second Quarter of 2020
7:01am
8-K
6as42n
3 Dec 19
Regulation FD Disclosure
8:00am
8-K
EX-99.1
4xa7 tbbc8r3
6 Nov 19
Aeglea BioTherapeutics Reports Third Quarter 2019 Financial Results and Corporate Highlights
8:30am
8-K
98owl
3 Sep 19
Aeglea BioTherapeutics Announces Positive 20-Dose Data for Pegzilarginase in Patients with Arginase 1 Deficiency at the 2019 SSIEM Symposium
6:03am
8-K
EX-99.1
gl49n3thz2hzk ghm
3 Sep 19
Aeglea BioTherapeutics Announces Positive 20-Dose Data for Pegzilarginase in Patients with Arginase 1 Deficiency at the 2019 SSIEM Symposium
6:03am
8-K
EX-99.1
w6vcx5lt
6 Aug 19
Aeglea BioTherapeutics Reports Second Quarter 2019 Financial Results and Corporate Highlights
8:00am
8-K
EX-99.1
2f798evlbazwm6rf1ctn
7 May 19
Aeglea BioTherapeutics Reports First Quarter 2019 Financial Results and Corporate Highlights
7:45am
8-K
EX-99.1
zgu2z6c
8 Apr 19
Regulation FD Disclosure
6:05am
S-8
l5ft9rl1o6t4nxqs
7 Mar 19
Registration of securities for employees
5:16pm